Related Experiment Video
Updated: Nov 24, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Current Status and Future Direction of Hepatic Radioembolisation
A A Alsultan1, A J A T Braat1, M L J Smits1
1Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
Abstract:
Radioembolisation is a locoregional treatment modality for hepatic malignancies. It consists of several stages that are vital to its success, which include a pre-treatment angiographic simulation followed by nuclear medicine imaging, treatment activity choice, treatment procedure and post-treatment imaging. All these stages have seen much advancement over the past decade. Here we aim to provide an overview of the practice of radioembolisation, discuss the limitations of currently applied methods and explore promising developments.

